The need for a review journal of drug use and the elderly

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026

Real-world treatment patterns and cost per patient achieving treatment targets among tirzepatide and semaglutide initiators in US patients with type 2 diabetes.

Journal of managed care & specialty pharmacy·2026

Return on investment of SGLT2 inhibitors and GLP-1 receptor agonists: Implications of real-world use for managed care.

Journal of managed care & specialty pharmacy·2026

Trends in annual medication possession in older adults with type 2 diabetes.

Journal of managed care & specialty pharmacy·2026

The site of absorption matters: Small bowel dysmotility and levodopa pharmacokinetics in Parkinson's disease.

Journal of Parkinson's disease·2026

Related Experiment Videos

The need for a review journal of drug use and the elderly

Related Concept Videos

Free-flight encounters between praying mantids (Parasphendale agrionina) and bats (Eptesicus fuscus).

Mode of action and adverse effects of lipid lowering drugs.

Effect of grapefruit juice on pharmacokinetics and pharmacodynamics of verapamil enantiomers in healthy volunteers.

Prophylactic sodium valproate therapy in patients with drug-resistant migraine.

Tolerance and side-effects of paroxetine in elderly depressed patients.

Chronic lithium neurotoxicity presenting as Parkinson's disease.

Medication Appropriateness and Potentially Inappropriate Medications in Older Critical Care Patients: A Scoping Review.

Risk of Dementia With Renin-Angiotensin System Inhibitors Versus Calcium Channel Blockers in Hypertensive Adults: A Nationwide Multicenter Study.

Differences in Anticholinergic Exposure Assessment Across Burden Scales and Exposure Measures in a Population-Based Study: Implications for Targeted Deprescribing in Older Adults.

Creating Awareness of preScribing Cascades and Managing Adverse Drug Effects (CASC-ADE) Tool: Appraisal by Future End Users.

Influence of Ageing on the Pharmacology, Efficacy and Safety of Oral Targeted Therapies for Inflammatory Bowel Disease: Focus on Janus Kinase (JAK) Inhibitors and Sphingosine-1-Phosphate (S1P) Receptor Modulators.

Longitudinal Adherence Trajectories of First-Line Nucleotide Analogues among US Older Adults with Chronic Hepatitis B.

Gastrointestinal adverse effects of GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists: A narrative expert review of approved therapies, oral formulations, and pipeline agents.

Uncovering hypothesis-generating associations between prescription drugs and digestive cancer risk: a case-control drug-wide association study (DWAS).

Real-world treatment patterns and cost per patient achieving treatment targets among tirzepatide and semaglutide initiators in US patients with type 2 diabetes.

Return on investment of SGLT2 inhibitors and GLP-1 receptor agonists: Implications of real-world use for managed care.

Trends in annual medication possession in older adults with type 2 diabetes.

The site of absorption matters: Small bowel dysmotility and levodopa pharmacokinetics in Parkinson's disease.

Related Experiment Videos

The need for a review journal of drug use and the elderly

Related Concept Videos

Related Articles